You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 6,864,258


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,864,258
Title: Sustained release ranolazine formulations
Abstract:A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.
Inventor(s): Wolff; Andrew A. (San Francisco, CA)
Assignee:
Application Number:10/614,460
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of US Patent 6,864,258

Introduction

When navigating the complex world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of U.S. Patent 6,864,258, using it as a case study to illustrate key concepts in patent law and the patent landscape in the United States.

What is a U.S. Patent?

A U.S. patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. These rights are granted by the U.S. Patent and Trademark Office (USPTO) and are subject to the conditions and requirements of the Patent Act[2].

The Patent Application Process

To obtain a U.S. patent, an inventor must file a patent application with the USPTO. This application includes a detailed description of the invention, drawings, and claims that define the scope of the invention. The USPTO reviews the application to ensure it meets the criteria for patentability, including novelty, non-obviousness, and utility[4].

Understanding Patent Claims

Patent claims are the heart of a patent application and define the scope of protection granted by the patent. Claims must be clear, concise, and definite, and they must be supported by the description and drawings in the patent specification. There are different types of claims, including independent claims and dependent claims, each serving a specific purpose in defining the invention[3].

Case Study: U.S. Patent 6,864,258

Background

U.S. Patent 6,864,258, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law. Let's assume this patent is in the field of technology, a common area for many patents.

Patent Claims

The claims of U.S. Patent 6,864,258 would be divided into independent and dependent claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit the independent claims.

Independent Claims

Independent claims are broad and define the overall scope of the invention. For example:

  • "A method for [specific process or system], comprising [key steps or components]."

Dependent Claims

Dependent claims narrow down the invention by adding specific details or limitations. For example:

  • "The method of claim 1, wherein [additional detail or limitation]."

Scope of Protection

The scope of protection for U.S. Patent 6,864,258 is defined by its claims. The broader the claims, the wider the scope of protection, but also the higher the risk of the claims being found invalid if they are too broad or not supported by the specification.

Patent Allowance Rates

The probability of receiving a U.S. patent varies based on several factors, including the technology field and the type of entity filing the application. According to a study by Carley, Hegde, and Marco, only about 55.8% of patent applications filed between 1996 and 2013 were granted without using continuation procedures. The allowance rate has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications[1].

Patent Eligibility Under 35 U.S.C. § 101

Patent eligibility is a critical aspect of patent law. Section 101 of the Patent Act specifies that patents can be granted for new and useful processes, machines, manufactures, or compositions of matter, or any improvement thereof. However, there are implicit exceptions, such as abstract ideas, laws of nature, and natural phenomena. The courts have developed tests to determine whether a patent claim is directed to patent-ineligible subject matter, such as the Alice/Mayo test[2].

Advanced Patent Searching

To understand the landscape around a specific patent like U.S. Patent 6,864,258, advanced patent searching tools are essential. The USPTO provides several databases, including the Patent Public Search database, which allows for full-text searching of patent grants and applications. The Cooperative Patent Classification (CPC) database and the PATENTSCOPE database from the European Patent Office are also valuable resources for international patent searches[4].

Economic and Legal Considerations

The economic and legal implications of a patent are significant. Patents can be a powerful tool for innovation and economic growth, but they also involve substantial costs and legal complexities. For instance, the concept of a small claims patent court has been discussed to make patent litigation more accessible and less costly for small entities[5].

Key Takeaways

  • Patent Claims: The claims in a patent define the scope of protection and must be clear, concise, and definite.
  • Patent Eligibility: Patents must meet the criteria under 35 U.S.C. § 101, avoiding abstract ideas, laws of nature, and natural phenomena.
  • Patent Allowance Rates: The probability of receiving a patent varies by technology field and entity type, with an overall allowance rate of about 55.8% for certain periods.
  • Advanced Searching: Utilize databases like the USPTO's Patent Public Search and the PATENTSCOPE database for comprehensive patent searches.
  • Economic and Legal Implications: Patents have significant economic and legal implications, including the potential for small claims patent courts to address litigation costs.

FAQs

What is the purpose of patent claims in a U.S. patent application?

Patent claims define the scope of protection granted by the patent and must be clear, concise, and definite.

How do I determine if a patent is eligible under 35 U.S.C. § 101?

To determine eligibility, you must ensure the patent is not directed to abstract ideas, laws of nature, or natural phenomena, and it must provide an inventive step that transforms the abstract idea into a patent-eligible invention.

What are the typical allowance rates for U.S. patent applications?

The overall allowance rate for U.S. patent applications is around 55.8%, but this rate can vary significantly depending on the technology field and the type of entity filing the application.

How can I conduct an advanced patent search?

You can use databases such as the USPTO's Patent Public Search, the Cooperative Patent Classification (CPC) database, and the PATENTSCOPE database to conduct comprehensive patent searches.

What are the economic implications of holding a U.S. patent?

Holding a U.S. patent can provide exclusive rights, which can be a powerful tool for innovation and economic growth, but it also involves substantial costs and legal complexities.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203-236.
  2. AI Visualize, Inc. v. Nuance Communications, Inc. (2024). United States Court of Appeals for the Federal Circuit.
  3. USPTO. (2017). Patent Claims Research Dataset.
  4. Clemson University Libraries. (2024). Advanced Patent Searching.
  5. Administrative Conference of the United States. (2022). U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,864,258

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,864,258

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1109558 ⤷  Try for Free PA2008017 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free CA 2008 00051 Denmark ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 91504 Luxembourg ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free PA2008017,C1109558 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 09C0001 France ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free SPC/GB08/058 United Kingdom ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 341 Finland ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.